China News on May 16 talked about China's nucleic acid detection capabilities. Guo Yanhong, supervisor of the Medical and Medical Administration of the National Health Commission, said on the 16th that up to now, the daily detection capacity can reach 1.5 million copies.
Data figure: The staff of Shanghai Lanwei Medical Laboratory is performing nucleic acid detection on the samples sent. Photo by Yin Liqin
On the afternoon of the 16th, the joint prevention and control mechanism of the State Council held a press conference on medical assistance to Hubei and the restoration of normal medical treatment. At the meeting, Guo Yanhong pointed out that in the early stage of epidemic prevention and control, the nucleic acid testing of New Coronavirus mainly relies on disease control institutions. For nucleic acid testing, a P2 laboratory, which is a second-level biosecurity laboratory, is required for indoor quality assessment and time. Quality control, etc. have relatively high requirements. With the increasing number of cases, the improvement of nucleic acid detection capacity and efficiency has become a bottleneck problem. At the end of January, the National Health and Health Commission required that as long as qualified medical institutions in all regions can carry out new coronary pneumonia nucleic acid through the record Testing work.
Guo Yanhong said that at present, with our requirements for medical institutions and the corresponding testing departments, as of now, our daily testing capacity can reach 1.5 million copies.
"With the resumption of production and production, the scope of detection will be further expanded, and the nucleic acid detection capacity needs to be further improved. Next, on the one hand, we must strengthen the laboratory construction of medical institutions above the second level to meet the requirements for nucleic acid detection. At the same time, in addition to hardware construction, Software is also very important. On the one hand, the software is biological safety management, on the one hand, it is quality control work and standardized operation of medical staff. "Guo Yanhong said.
Guo Yanhong said that the next step will be to strengthen biosafety management and laboratory management, especially the training of medical personnel, to adapt to the needs of medical services and nucleic acid detection in the whole society after resuming production.